Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 5,994 shares at $37.43 ($225K) on 2014-12-01, disclosed to the SEC on 2014-12-02.
Scheduled sale ($225k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.43 | 3,994 | $149K | 66.3% |
| 2 | $37.90 | 1,900 | $72K | 32.0% |
| 3 | $38.20 | 100 | $4K | 1.7% |
| Total | $37.59 avg | 5,994 | $225K | 100% |
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |